Abstract:The amyloid precursor protein (APP) is linked to the genetics and pathogenesis of Alzheimer's disease (AD). It is the parent protein of the β-amyloid (Aβ) peptide, the main constituent of the amyloid plaques found in an AD brain. The pathways from APP to Aβ are intensively studied, yet the normal functions of APP itself have generated less interest. We report here that glutamate stimulation of neuronal activity leads to a rapid increase in App gene expression. In mouse and human neurons, elevated APP protein changes the structure of the axon initial segment (AIS) where action potentials are initiated. The AIS is shortened in length and shifts away from the cell body. The GCaMP8f Ca 2+ reporter confirms the predicted decrease in neuronal activity. NMDA antagonists or knockdown of App block the glutamate effects. The actions of APP on the AIS are cell-autonomous; exogenous Aβ, either fibrillar or oligomeric, has no effect. In culture, APP Swe (a familial AD mutation) induces larger AIS changes than wild type APP. Ankyrin G and βIV-spectrin, scaffolding proteins of the AIS, both physically associate with APP, more so in AD brains. Finally, in humans with sporadic AD or in the R1.40 AD mouse model, both females and males, neurons have elevated levels of APP protein that invade the AIS. In vivo as in vitro , this increased APP is associated with a significant shortening of the AIS. The findings outline a new role for the APP and encourage a reconsideration of its relationship to AD. SIGNIFICANCE STATEMENT While the amyloid precursor protein (APP) has long been associated with Alzheimer's disease (AD), the normal functions of the full-length Type I membrane protein have been largely unexplored. We report here that the levels of APP protein increase with neuronal activity. In vivo and in vitro , modest amounts of excess APP alter the properties of the axon initial segment. The β-amyloid peptide derived from APP is without effect. Consistent with the observed changes in the axon initial segment which would be expected to decrease action potential firing, we show that APP expression depresses neuronal activity. In mouse AD models and human sporadic AD, APP physically associates with the scaffolding proteins of the axon initial segment, suggesting a relationship with AD dementia.

A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis

Proteomic Analysis of Astrocytic Secretion That Regulates Neurogenesis Using Quantitative Amine-Specific Isobaric Tagging.

Amyloid precursor protein intracellular domain-dependent regulation of FOXO3a inhibits adult hippocampal neurogenesis

Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis Via Regulating the Sensitivity of Glucocorticoid Receptor.

The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth

Wnt/β-catenin Signal Pathway Stabilizes APP Intracellular Domain (AICD) and Promotes Its Transcriptional Activity

APP and its intracellular domain modulate Alzheimer’s disease risk gene networks in transgenic and porcine models

Mutations in APP have independent effects on Aβ and CTFγ generation

BAG-1M Co-Activates BACE1 Transcription Through NF-κB and Accelerates Aβ Production and Memory Deficit in Alzheimer's Disease Mouse Model.

BACE1 Regulates Hippocampal Astrogenesis Via the Jagged1-Notch Pathway

SNX15 Regulates Cell Surface Recycling of APP and Aβ Generation

The Amyloid Precursor Protein Modulates the Position and Length of the Axon Initial Segment

Mutations in APP have independent effects on Abeta and CTFgamma generation.

Amyloid precursor protein binds with TNFRSF21 to induce neural inflammation in Alzheimer’s Disease

Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway

Interplay between APP and glypican-1 processing and α-synuclein aggregation in undifferentiated and differentiated human neural progenitor cells

AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice

Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis

Extracellular disposal of nuclear waste by APP: a protective mechanism impaired in Alzheimer’s disease

Modulating Adult Neurogenesis Affects Synaptic Plasticity and Cognitive Functions in Mouse Models of Alzheimer's Disease.

APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ